|
1
|
Cascella M, Rajnik M, Aleem A, Dulebohn SC
and Di Napoli R: Features, evaluation, and treatment of coronavirus
(COVID-19) [Updated 2023 Aug 18]. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available
from: https://www.ncbi.nlm.nih.gov/books/NBK554776/.
|
|
2
|
Sheleme T, Bekele F and Ayela T: Clinical
presentation of patients infected with coronavirus disease 19: A
systematic review. Infect Dis (Auckl).
13(1178633720952076)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Siafarikas C, Stafylidis C, Tentolouris A,
Samara S, Eliadi I, Makrodimitri S, Spandidos DA, Mathioudakis N,
Karamichalos P, Papalexis P, et al: Radiologically suspected
COVID-19-associated organizing pneumonia responding well to
corticosteroids: A report of two cases and a review of the
literature. Exp Ther Med. 24(453)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Georgakopoulou VE, Gkoufa A, Damaskos C,
Papalexis P, Pierrakou A, Makrodimitri S, Sypsa G, Apostolou A,
Asimakopoulou S, Chlapoutakis S, et al: COVID-19-associated acute
appendicitis in adults. A report of five cases and a review of the
literature. Exp Ther Med. 24(482)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cholongitas E, Bali T, Georgakopoulou VE,
Giannakodimos A, Gyftopoulos A, Georgilaki V, Gerogiannis D,
Basoulis D, Eliadi I, Karamanakos G, et al: Prevalence of abnormal
liver biochemistry and its impact on COVID-19 patients' outcomes: A
single-center Greek study. Ann Gastroenterol. 35:290–296.
2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Georgakopoulou VE, Avramopoulos P,
Papalexis P, Bitsani A, Damaskos C, Garmpi A, Venetikou MS,
Paramythiotis D, Karlafti E, Sklapani P, et al: COVID-19 induced
hypoparathyroidism: A case report. Exp Ther Med.
23(346)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Georgakopoulou VE, Gkoufa A, Garmpis N,
Makrodimitri S, Papageorgiou CV, Barlampa D, Garmpi A, Chiapoutakis
S, Sklapani P, Trakas N and Damaskos C: COVID-19 and acute
pancreatitis: A systematic review of case reports and case series.
Ann Saudi Med. 42:276–287. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S,
Huang H, Zhang L, Zhou X, Du C, et al: Risk factors associated with
Acute respiratory distress syndrome and death in patients with
coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern
Med. 180:934–943. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cevik M, Tate M, Lloyd O, Maraolo AE,
Schafers J and Ho A: SARS-CoV-2, SARS-CoV, and MERS-CoV viral load
dynamics, duration of viral shedding, and infectiousness: A
systematic review and meta-analysis. Lancet Microbe. 2:e13–e22.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Georgakopoulou VE, Gkoufa A, Bougea A,
Basoulis D, Tsakanikas A, Makrodimitri S, Karamanakos G, Spandidos
DA, Angelopoulou E and Sipsas NV: Characteristics and outcomes of
elderly patients with Parkinson's disease hospitalized due to
COVID-19-associated pneumonia. Med Int (Lond). 3(34)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gkoufa A, Maneta E, Ntoumas GN,
Georgakopoulou VE, Mantelou A, Kokkoris S and Routsi C: Elderly
adults with COVID-19 admitted to intensive care unit: A narrative
review. World J Crit Care Med. 10:278–289. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lempesis IG and Georgakopoulou VE:
Implications of obesity and adiposopathy on respiratory infections;
focus on emerging challenges. World J Clin Cases. 11:2925–2933.
2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han
Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: A descriptive study. Lancet. 395:507–513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Thaweethai T, Jolley SE, Karlson EW,
Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN,
Parthasarathy S, Singh U, et al: Development of a definition of
postacute sequelae of SARS-CoV-2 infection. JAMA. 329:1934–1946.
2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Efstathiou V, Stefanou MI, Demetriou M,
Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Kympouropoulos
SP, Tsoporis JN, Spandidos DA, et al: Long COVID and
neuropsychiatric manifestations (review). Exp Ther Med.
23(363)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Efstathiou V, Stefanou MI, Demetriou M,
Siafakas N, Katsantoni E, Makris M, Tsivgoulis G, Zoumpourlis V,
Kympouropoulos SP, Tsoporis JN, et al: New-onset neuropsychiatric
sequelae and ‘long-COVID’ syndrome (Review). Exp Ther Med.
24(705)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Daugherty SE, Guo Y, Heath K, Dasmariñas
MC, Jubilo KG, Samranvedhya J, Lipsitch M and Cohen K: Risk of
clinical sequelae after the acute phase of SARS-CoV-2 infection:
Retrospective cohort study. BMJ. 373(n1098)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Huang C, Huang L, Wang Y, Li X, Ren L, Gu
X, Kang L, Guo L, Liu M, Zhou X, et al: 6-Month consequences of
COVID-19 in patients discharged from hospital: a cohort study.
Lancet. 397:220–232. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huang L, Li X, Gu X, Zhang H, Ren L, Guo
L, Liu M, Wang Y, Cui D, Wang Y, et al: Health outcomes in people 2
years after surviving hospitalisation with COVID-19: A longitudinal
cohort study. Lancet Respir Med. 10:863–876. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
E E, R F, Öi E, Im L, M L, S R, E W, C J,
M H and A M: Impaired diffusing capacity for carbon monoxide is
common in critically ill Covid-19 patients at four months
post-discharge. Respir Med. 182(106394)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Riou M, MarcoT C, Oulehri W, Enache I,
Pistea C, Chatron E, Labani A, Geny B, Ohana M, De Blay F, et al:
Respiratory follow-up after hospitalization for COVID-19: Who and
when? Eur J Clin Invest. 51(e13603)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shah AS, Wong AW, Hague CJ, Murphy DT,
Johnston JC, Ryerson CJ and Carlsten C: A prospective study of
12-week respiratory outcomes in COVID-19-related hospitalisations.
Thorax. 76:402–404. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee JH, Yim JJ and Park J: Pulmonary
function and chest computed tomography abnormalities 6-12 months
after recovery from COVID-19: A systematic review and
meta-analysis. Respir Res. 23(233)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K,
Chen H, Zeng Z, Qin Y, Wang H, et al: Twelve-month systemic
consequences of coronavirus disease 2019 (COVID-19) in patients
discharged from hospital: A prospective cohort study in Wuhan,
China. Clin Infect Dis. 74:1953–1965. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang L, Berger NA, Kaelber DC, Davis PB,
Volkow ND and Xu R: COVID infection rates, clinical outcomes, and
racial/ethnic and gender disparities before and after omicron
emerged in the US medRxiv: Feb 22, 2022 (Epub ahead of print).
|
|
26
|
Abdullah F, Myers J, Basu D, Tintinger G,
Ueckermann V, Mathebula M, Ramlall R, Spoor S, de Villiers T, Van
der Walt Z, et al: Decreased severity of disease during the first
global omicron variant covid-19 outbreak in a large hospital in
Tshwane, South Africa. Int J Infect Dis. 116:38–42. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Arabi M, Al-Najjar Y, Mhaimeed N, Salameh
MA, Paul P, AlAnni J, Abdelati AA, Laswi I, Khanjar B, Al-Ali D, et
al: Severity of the omicron SARS-CoV-2 variant compared with the
previous lineages: A systematic review. J Cell Mol Med.
27:1443–1464. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Antonelli M, Pujol JC, Spector TD,
Ourselin S and Steves CJ: Risk of long COVID associated with delta
versus omicron variants of SARS-CoV-2. Lancet. 399:2263–2264.
2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Quanjer PH, Tammeling GJ, Cotes JE,
Pedersen OF, Peslin R and Yernault JC: Lung volumes and forced
ventilatory flows. Report working party standardization of lung
function tests, European community for steel and coal. Official
statement of the European respiratory society. Eur Respir J Suppl.
16:5–40. 1993.PubMed/NCBI
|
|
30
|
Georgakopoulou VE, Asimakopoulou S and
Cholongitas E: Pulmonary function testing in patients with liver
cirrhosis (review). Med Int (Lond). 3(36)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cotes JE, Chinn DJ, Quanjer PH, Roca J and
Yernault JC: Standardization of the measurement of transfer factor
(diffusing capacity). Eur Respir J. 6 (Suppl 16):S41–S52.
1993.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Karampitsakos T, Sotiropoulou V, Katsaras
M, Tsiri P, Georgakopoulou VE, Papanikolaou IC, Bibaki E, Tomos I,
Lambiri I, Papaioannou O, et al: Post-COVID-19 interstitial lung
disease: Insights from a machine learning radiographic model. Front
Med (Lausanne). 9(1083264)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang
Y, Hu P, Guo L, Liu M, Xu J, et al: 1-Year outcomes in hospital
survivors with COVID-19: A longitudinal cohort study. Lancet.
398:747–758. 2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang C, Ramasamy A, Verduzco-Gutierrez M,
Brode WM and Melamed E: Acute and post-acute sequelae of SARS-CoV-2
infection: A review of risk factors and social determinants. Virol
J. 20(124)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tarraso J, Safont B, Carbonell-Asins JA,
Fernandez-Fabrellas E, Sancho-Chust JN, Naval E, Amat B, Herrera S,
Ros JA, Soler-Cataluña JJ, et al: Lung function and radiological
findings 1 year after COVID-19: A prospective follow-up. Respir
Res. 23(242)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Schneider JL, Rowe JH, Garcia-de-Alba C,
Kim CF, Sharpe AH and Haigis MC: The aging lung: Physiology,
disease, and immunity. Cell. 184:1990–2019. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Aghali A, Koloko Ngassie ML, Pabelick CM
and Prakash YS: Cellular senescence in aging lungs and diseases.
Cells. 11(1781)2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cho SJ and Stout-Delgado HW: Aging and
lung disease. Annu Rev Physiol. 82:433–459. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tsampasian V, Elghazaly H, Chattopadhyay
R, Debski M, Naing TKP, Garg P, Clark A, Ntatsaki E and Vassiliou
VS: Risk factors associated with post-COVID-19 condition: A
systematic review and meta-analysis. JAMA Intern Med. 183:566–580.
2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Bai F, Tomasoni D, Falcinella C,
Barbanotti D, Castoldi R, Mulè G, Augello M, Mondatore D, Allegrini
M, Cona A, et al: Female gender is associated with long COVID
syndrome: A prospective cohort study. Clin Microbiol Infect.
28:611.e9–611.e16. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Torjesen I: Covid-19: Middle aged women
face greater risk of debilitating long term symptoms. BMJ.
372(n829)2021.PubMed/NCBI View
Article : Google Scholar
|
|
42
|
Opsteen S, Files JK, Fram T and Erdmann N:
The role of immune activation and antigen persistence in acute and
long COVID. J Investig Med. 71:545–562. 2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Phetsouphanh C, Darley DR, Wilson DB, Howe
A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et
al: Immunological dysfunction persists for 8 months following
initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol.
23:210–216. 2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Souyris M, Mejía JE, Chaumeil J and Guéry
JC: Female predisposition to TLR7-driven autoimmunity: Gene dosage
and the escape from X chromosome inactivation. Semin Immunopathol.
41:153–164. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hanidziar D and Robson SC: Hyperoxia and
modulation of pulmonary vascular and immune responses in COVID-19.
Am J Physiol Lung Cell Mol Physiol. 320:L12–L16. 2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Patel BV, Arachchillage DJ, Ridge CA,
Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M,
Price S, et al: Pulmonary angiopathy in severe COVID-19:
Physiologic, imaging, and hematologic observations. Am J Respir
Crit Care Med. 202:690–699. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Silveyra P, Fuentes N and Rodriguez Bauza
DE: Sex and gender differences in lung disease. Adv Exp Med Biol.
1304:227–258. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Trakas N, Georgakopoulou VE, Melemeni D,
Damaskos C, Mantzouranis K, Garmpis N, Gkoufa A, Papalexis P,
Chlapoutakis S, Sklapani P, et al: Association between smoking
cessation and alterations in forced expiratory volume in one second
(FEV1). A follow-up study from a Greek tobacco cessation clinic.
Addict Health. 14:87–95. 2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Barthélémy H, Mougenot E, Duracinsky M,
Salmon-Ceron D, Bonini J, Péretz F, Chassany O and Carrieri P:
Smoking increases the risk of post-acute COVID-19 syndrome: Results
from a French community-based survey. Tob Induc Dis.
20(59)2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Martinez-Pitre PJ, Sabbula BR and Cascella
M: Restrictive lung disease. In: StatPearls. StatPearls Publishing,
Treasure Island, FL, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560880/.
|
